- Q1 2024 Cytek Biosciences Inc Earnings Call TranscriptMay 08, 2024$6.27 (-1.72%)Earnings
- Q4 2023 Cytek Biosciences Inc Earnings Call TranscriptFeb 28, 2024$8.74 (-1.24%)Earnings
- Cytek Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Cytek Biosciences Inc Earnings Call TranscriptNov 07, 2023$4.45 (+2.06%)Earnings
- Cytek Biosciences Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Cytek Biosciences Inc Earnings Call TranscriptAug 08, 2023$8.92 (-2.73%)Earnings
- Cytek Biosciences Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Q1 2023 Cytek Biosciences Inc Earnings Call TranscriptMay 09, 2023$11.67 (+0.60%)Earnings
- Q4 2022 Cytek Biosciences Inc Earnings Call TranscriptFeb 28, 2023$10.3 (-2.28%)Earnings
- Cytek Biosciences Inc To Acquire Flow Cytometry and Imaging Business From DiaSorin- M&A Call TranscriptFeb 13, 2023
- Cytek Biosciences Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Cytek Biosciences Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Cytek Biosciences Inc Earnings Call TranscriptNov 09, 2022$13.7 (-5.65%)Earnings
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Cytek Biosciences Inc Earnings Call TranscriptAug 10, 2022$15.45 (+5.17%)Earnings
- Cytek Biosciences Inc Corporate Analyst Meeting TranscriptJun 22, 2022
- Q1 2022 Cytek Biosciences Inc Earnings Call TranscriptMay 11, 2022$7.41 (-7.84%)Earnings
- Q4 2021 Cytek Biosciences Inc Earnings Call TranscriptFeb 23, 2022$13.12 (-2.53%)Earnings
- Q3 2021 Cytek Biosciences Inc Earnings Call TranscriptNov 08, 2021$25.04 (+1.34%)Earnings
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
Cytek Biosciences Inc To Acquire Flow Cytometry and Imaging Business From DiaSorin- M&A Call Transcript
Hello, and thank you for standing by. Welcome to Cytek Biosciences conference call. (Operator Instructions)
I would now like to turn the conference over to your speaker for today, Dr. Wenbin Jiang, CEO. You may begin, sir.
Thank you for joining our call to discuss Cytek's acquisition of the Flow Cytometry business from Luminex Corporation. Luminex will continue to be owned by DiaSorin of Saluggia, Italy.
I want to remind everyone listening today that we will be making forward-looking statements as part of this presentation. These forward-looking statements are associated with a number of risks and uncertainties that cause -- could cause actual results to differ materially from currently anticipated results. Please read this statement to learn more about these risks and uncertainties.
I want to start by reviewing the overarching corporate growth we have at Cytek, which guide our key decision-making and operations. I'm pleased to say that the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)